Egypt's Petroleum Min. promotes mining investment in London with new incentives    Egypt recovers two ancient artefacts from Belgium    Oil prices edged lower on Wednesday    Gold prices rebound on Wednesday    Egypt unveils ambitious strategy to boost D-8 intra-trade to $500bn by 2030    Egypt discusses rehabilitating Iraqi factories, supplying defence equipment at EDEX 2025    Private Egyptian firm Tornex target drones and logistics UAVs at EDEX 2025    Egypt's Abdelatty urges deployment of international stabilisation force in Gaza during Berlin talks    Egypt begins training Palestinian police as pressure mounts to accelerate Gaza reconstruction    Egypt opens COP24 Mediterranean, urges faster transition to sustainable blue economy    Egypt's Health Minister leads high-level meeting to safeguard medicine, medical supply chains    AOI, Dassault sign new partnership to advance defense industrial cooperation    Egypt, Saudi nuclear authorities sign MoU to boost cooperation on nuclear safety    US Embassy marks 70th anniversary of American Center Cairo    Giza master plan targets major hotel expansion to match Grand Egyptian Museum launch    Australia returns 17 rare ancient Egyptian artefacts    China invites Egypt to join African duty-free export scheme    Egypt calls for stronger Africa-Europe partnership at Luanda summit    Egypt begins 2nd round of parliamentary elections with 34.6m eligible voters    Egypt warns of erratic Ethiopian dam operations after sharp swings in Blue Nile flows    Egypt scraps parliamentary election results in 19 districts over violations    Egypt extends Ramses II Tokyo Exhibition as it draws 350k visitors to date    Egypt signs host agreement for Barcelona Convention COP24 in December    Al-Sisi urges probe into election events, says vote could be cancelled if necessary    Filmmakers, experts to discuss teen mental health at Cairo festival panel    Cairo International Film Festival to premiere 'Malaga Alley,' honour Khaled El Nabawy    Egypt golf team reclaims Arab standing with silver; Omar Hisham Talaat congratulates team    Egypt launches National Strategy for Rare Diseases at PHDC'25    Egypt adds trachoma elimination to health success track record: WHO    Egypt launches Red Sea Open to boost tourism, international profile    Omar Hisham Talaat: Media partnership with 'On Sports' key to promoting Egyptian golf tourism    Sisi expands national support fund to include diplomats who died on duty    Egypt's PM reviews efforts to remove Nile River encroachments    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Drugmaker GSK investigating corruption allegations in UAE
British drugmaker GSK is investigating alleged bribery in Emirates based on an email by a whistleblower after the company was hit by a big fine for corruption in China
Reuters Published in Ahram Online on 08 - 10 - 2014

Drugmaker GlaxoSmithKline, which was slapped with a record $489 million (304.26 million pound) fine for corruption in China last month, said on Tuesday it was looking into allegations of corruption in the United Arab Emirates.
Britain's biggest pharmaceuticals group confirmed the investigation following allegations of improper payments set out in a whistleblower's email sent to its top management on Monday. The email, purporting to be from a GSK sales manager in the Gulf state, was seen by Reuters.
The company is already investigating alleged bribery in a number of Middle East countries, including Lebanon, Jordan, Syria and Iraq, as well as Poland.
"As we have already said, we are undertaking an investigation into our operations in the Middle East following complaints made previously. This investigation continues and these specific claims were already being investigated as part of this process," a GSK spokesman said.
GSK and other major drugmakers are under increased scrutiny in the wake of the high-profile Chinese case and law enforcement agencies in both the United States and Britain are clamping down on overseas corruption by multinational companies.
The China scandal has hit GSK's drug sales in the country and tarnished the reputation of Chief Executive Andrew Witty.
Other pharmaceutical companies, too, are in the firing line for alleged improper sales behaviour.
France's Sanofi said on Monday it had informed U.S. authorities of allegations of improper payments by its employees to healthcare professionals in East Africa and the Middle East.
Novartis, meanwhile, has been ordered to face a U.S. government lawsuit accusing the Swiss drugmaker of paying multimillion-dollar kickbacks.
And two women in Poland have pleaded guilty to bribery in another case involving an unnamed company.
In the case involving GSK's practices in the UAE, the anonymous author of the email claimed that the British company made direct payments to healthcare professionals, hospitals, clinics and pharmacies to secure business.
This included payments for educational meetings -- regardless of whether or not they took place -- as well as schemes to pay customers for taking prescription drugs by giving them bonus over-the-counter products, the author said.
"We have zero tolerance for unethical behaviour and we welcome people speaking up if they have concerns about alleged misconduct. We are committed to taking any disciplinary actions resulting from the findings," the GSK spokesman said.
http://english.ahram.org.eg/News/112574.aspx

Clic here to read the story from its source.